ID   MYO3A_HUMAN             Reviewed;        1616 AA.
AC   Q8NEV4; Q4G0X2; Q5VZ28; Q8WX17; Q9NYS8;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   10-MAY-2017, entry version 146.
DE   RecName: Full=Myosin-IIIa;
DE            EC=2.7.11.1;
GN   Name=MYO3A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT SER-1313.
RX   PubMed=10936054; DOI=10.1006/geno.2000.6256;
RA   Dose A.C., Burnside B.;
RT   "Cloning and chromosomal localization of a human class III myosin.";
RL   Genomics 67:333-342(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT SER-1313, INVOLVEMENT
RP   IN DFNB30, AND FUNCTION.
RX   PubMed=12032315; DOI=10.1073/pnas.102091699;
RA   Walsh T., Walsh V., Vreugde S., Hertzano R., Shahin H., Haika S.,
RA   Lee M.K., Kanaan M., King M.-C., Avraham K.B.;
RT   "From flies' eyes to our ears: mutations in a human class III myosin
RT   cause progressive nonsyndromic hearing loss DFNB30.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7518-7523(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-178; HIS-319; VAL-348; ILE-369;
RP   LYS-525; SER-833; ASN-956; ARG-956; THR-1032; MET-1045; MET-1137;
RP   ALA-1195; SER-1284; THR-1287; SER-1313; HIS-1347; ILE-1417 AND
RP   GLU-1488.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Probable actin-based motor with a protein kinase
CC       activity. Probably plays a role in vision and hearing.
CC       {ECO:0000269|PubMed:12032315}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8NEV4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NEV4-2; Sequence=VSP_056231, VSP_056232;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Strongest expression in retina, retinal
CC       pigment epithelial cells, cochlea and pancreas.
CC   -!- DISEASE: Deafness, autosomal recessive, 30 (DFNB30) [MIM:607101]:
CC       A form of non-syndromic deafness characterized by bilateral
CC       progressive hearing loss, which first affects the high
CC       frequencies. Hearing loss begins in the second decade, and by age
CC       50 is severe in high and middle frequencies and moderate at low
CC       frequencies. {ECO:0000269|PubMed:12032315}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the TRAFAC class
CC       myosin-kinesin ATPase superfamily. Myosin family. {ECO:0000305}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the protein
CC       kinase superfamily. STE Ser/Thr protein kinase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF229172; AAF70861.1; -; mRNA.
DR   EMBL; AY101367; AAM34500.1; -; mRNA.
DR   EMBL; AL162503; CAH73661.1; -; Genomic_DNA.
DR   EMBL; AL358612; CAH73661.1; JOINED; Genomic_DNA.
DR   EMBL; AL360217; CAH73661.1; JOINED; Genomic_DNA.
DR   EMBL; AL391812; CAH73661.1; JOINED; Genomic_DNA.
DR   EMBL; AL358612; CAH73814.1; -; Genomic_DNA.
DR   EMBL; AL162503; CAH73814.1; JOINED; Genomic_DNA.
DR   EMBL; AL360217; CAH73814.1; JOINED; Genomic_DNA.
DR   EMBL; AL391812; CAH73814.1; JOINED; Genomic_DNA.
DR   EMBL; AL360217; CAD13206.2; -; Genomic_DNA.
DR   EMBL; AL391812; CAI17380.1; -; Genomic_DNA.
DR   EMBL; AL162503; CAI17380.1; JOINED; Genomic_DNA.
DR   EMBL; AL358612; CAI17380.1; JOINED; Genomic_DNA.
DR   EMBL; AL360217; CAI17380.1; JOINED; Genomic_DNA.
DR   EMBL; BC036079; AAH36079.1; -; mRNA.
DR   CCDS; CCDS7148.1; -. [Q8NEV4-1]
DR   RefSeq; NP_059129.3; NM_017433.4. [Q8NEV4-1]
DR   RefSeq; XP_011517800.1; XM_011519498.2. [Q8NEV4-1]
DR   RefSeq; XP_011517801.1; XM_011519499.1. [Q8NEV4-1]
DR   RefSeq; XP_011517802.1; XM_011519500.2. [Q8NEV4-1]
DR   UniGene; Hs.662630; -.
DR   ProteinModelPortal; Q8NEV4; -.
DR   SMR; Q8NEV4; -.
DR   BioGrid; 119814; 3.
DR   IntAct; Q8NEV4; 1.
DR   STRING; 9606.ENSP00000265944; -.
DR   BindingDB; Q8NEV4; -.
DR   ChEMBL; CHEMBL5546; -.
DR   GuidetoPHARMACOLOGY; 2112; -.
DR   iPTMnet; Q8NEV4; -.
DR   PhosphoSitePlus; Q8NEV4; -.
DR   BioMuta; MYO3A; -.
DR   DMDM; 160112826; -.
DR   EPD; Q8NEV4; -.
DR   PaxDb; Q8NEV4; -.
DR   PeptideAtlas; Q8NEV4; -.
DR   PRIDE; Q8NEV4; -.
DR   Ensembl; ENST00000265944; ENSP00000265944; ENSG00000095777. [Q8NEV4-1]
DR   Ensembl; ENST00000376302; ENSP00000365479; ENSG00000095777. [Q8NEV4-2]
DR   GeneID; 53904; -.
DR   KEGG; hsa:53904; -.
DR   UCSC; uc001ism.3; human. [Q8NEV4-1]
DR   CTD; 53904; -.
DR   DisGeNET; 53904; -.
DR   GeneCards; MYO3A; -.
DR   GeneReviews; MYO3A; -.
DR   H-InvDB; HIX0201520; -.
DR   HGNC; HGNC:7601; MYO3A.
DR   HPA; HPA048951; -.
DR   HPA; HPA051893; -.
DR   MalaCards; MYO3A; -.
DR   MIM; 606808; gene.
DR   MIM; 607101; phenotype.
DR   neXtProt; NX_Q8NEV4; -.
DR   OpenTargets; ENSG00000095777; -.
DR   Orphanet; 90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB.
DR   PharmGKB; PA31405; -.
DR   eggNOG; KOG0587; Eukaryota.
DR   eggNOG; KOG4229; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   GeneTree; ENSGT00840000129687; -.
DR   HOGENOM; HOG000234203; -.
DR   HOVERGEN; HBG052555; -.
DR   InParanoid; Q8NEV4; -.
DR   KO; K08834; -.
DR   OMA; NFRGHRE; -.
DR   OrthoDB; EOG091G00C2; -.
DR   PhylomeDB; Q8NEV4; -.
DR   TreeFam; TF326512; -.
DR   SignaLink; Q8NEV4; -.
DR   GeneWiki; MYO3A; -.
DR   GenomeRNAi; 53904; -.
DR   PRO; PR:Q8NEV4; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000095777; -.
DR   CleanEx; HS_MYO3A; -.
DR   ExpressionAtlas; Q8NEV4; baseline and differential.
DR   Genevisible; Q8NEV4; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0031941; C:filamentous actin; IDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IDA:UniProtKB.
DR   GO; GO:0016459; C:myosin complex; IEA:UniProtKB-KW.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030898; F:actin-dependent ATPase activity; IDA:UniProtKB.
DR   GO; GO:0043531; F:ADP binding; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0000146; F:microfilament motor activity; IDA:UniProtKB.
DR   GO; GO:0060002; F:plus-end directed microfilament motor activity; IDA:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:UniProtKB.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00612; IQ; 2.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 3.
DR   SMART; SM00242; MYSc; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50096; IQ; 3.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   2: Evidence at transcript level;
KW   Actin-binding; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Deafness; Hearing; Kinase; Motor protein;
KW   Myosin; Non-syndromic deafness; Nucleotide-binding; Polymorphism;
KW   Reference proteome; Repeat; Sensory transduction;
KW   Serine/threonine-protein kinase; Transferase; Vision.
FT   CHAIN         1   1616       Myosin-IIIa.
FT                                /FTId=PRO_0000086413.
FT   DOMAIN       21    287       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      338   1053       Myosin motor.
FT   DOMAIN     1055   1084       IQ 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN     1082   1111       IQ 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN     1346   1375       IQ 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   NP_BIND      27     35       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    150    150       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING      50     50       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   VAR_SEQ     245    247       NPP -> SDD (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056231.
FT   VAR_SEQ     248   1616       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056232.
FT   VARIANT     178    178       T -> I (in dbSNP:rs33968748).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040871.
FT   VARIANT     204    204       D -> N (in dbSNP:rs3737274).
FT                                /FTId=VAR_021866.
FT   VARIANT     319    319       R -> H (in dbSNP:rs3824700).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040872.
FT   VARIANT     348    348       I -> V (in dbSNP:rs3824699).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040873.
FT   VARIANT     369    369       V -> I (in dbSNP:rs3817420).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040874.
FT   VARIANT     525    525       N -> K (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040875.
FT   VARIANT     833    833       A -> S (in dbSNP:rs33947968).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040876.
FT   VARIANT     956    956       S -> N (in dbSNP:rs3758449).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_021867.
FT   VARIANT     956    956       S -> R (in an ovarian serous carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040877.
FT   VARIANT    1032   1032       A -> T (in dbSNP:rs34918608).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040878.
FT   VARIANT    1045   1045       V -> M (in dbSNP:rs35447806).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040879.
FT   VARIANT    1137   1137       V -> M (in dbSNP:rs35449183).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040880.
FT   VARIANT    1195   1195       V -> A (in dbSNP:rs35675577).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040881.
FT   VARIANT    1284   1284       T -> S (in dbSNP:rs3740231).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_033905.
FT   VARIANT    1287   1287       P -> T (in dbSNP:rs35575696).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040882.
FT   VARIANT    1313   1313       R -> S (in dbSNP:rs1999240).
FT                                {ECO:0000269|PubMed:10936054,
FT                                ECO:0000269|PubMed:12032315,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_022779.
FT   VARIANT    1347   1347       D -> H (in a renal clear cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040883.
FT   VARIANT    1417   1417       T -> I (in dbSNP:rs34151474).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040884.
FT   VARIANT    1488   1488       K -> E (in dbSNP:rs34204285).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040885.
FT   CONFLICT    418    418       M -> I (in Ref. 1 and 2). {ECO:0000305}.
FT   CONFLICT    636    636       A -> V (in Ref. 1 and 2). {ECO:0000305}.
FT   CONFLICT    848    851       RDTL -> KTLV (in Ref. 2; AAF70861).
FT                                {ECO:0000305}.
FT   CONFLICT    886    890       TKNVI -> LKML (in Ref. 2; AAF70861).
FT                                {ECO:0000305}.
FT   CONFLICT   1099   1099       R -> G (in Ref. 1 and 2). {ECO:0000305}.
FT   CONFLICT   1217   1217       S -> F (in Ref. 1 and 2). {ECO:0000305}.
FT   CONFLICT   1378   1378       R -> K (in Ref. 1 and 2). {ECO:0000305}.
SQ   SEQUENCE   1616 AA;  186208 MW;  7D126A7E22520574 CRC64;
     MFPLIGKTII FDNFPDPSDT WEITETIGKG TYGKVFKVLN KKNGQKAAVK ILDPIHDIDE
     EIEAEYNILK ALSDHPNVVR FYGIYFKKDK VNGDKLWLVL ELCSGGSVTD LVKGFLKRGE
     RMSEPLIAYI LHEALMGLQH LHNNKTIHRD VKGNNILLTT EGGVKLVDFG VSAQLTSTRH
     RRNTSVGTPF WMAPEVIACE QQLDTTYDAR CDTWSLGITA IELGDGDPPL ADLHPMRALF
     KIPRNPPPKL RQPELWSAEF NDFISKCLTK DYEKRPTVSE LLQHKFITQI EGKDVMLQKQ
     LTEFIGIHQC MGGTEKARRE RIHTKKGNFN RPLISNLKDV DDLATLEILD ENTVSEQLEK
     CYSRDQIYVY VGDILIALNP FQSLGLYSTK HSKLYIGSKR TASPPHIFAM ADLGYQSMIT
     YNSDQCIVIS GESGAGKTEN AHLLVQQLTV LGKANNRTLQ EKILQVNNLV EAFGNACTII
     NDNSSRFGKY LEMKFTSSGA VVGAQISEYL LEKSRVIHQA IGEKNFHIFY YIYAGLAEKK
     KLAHYKLPEN KPPRYLQNDH LRTVQDIMNN SFYKSQYELI EQCFKVIGFT MEQLGSIYSI
     LAAILNVGNI EFSSVATEHQ IDKSHISNHT ALENCASLLC IRADELQEAL TSHCVVTRGE
     TIIRPNTVEK ATDVRDAMAK TLYGRLFSWI VNCINSLLKH DSSPSGNGDE LSIGILDIFG
     FENFKKNSFE QLCINIANEQ IQYYYNQHVF AWEQNEYLNE DVDARVIEYE DNWPLLDMFL
     QKPMGLLSLL DEESRFPKAT DQTLVEKFEG NLKSQYFWRP KRMELSFGIH HYAGKVLYNA
     SGFLAKNRDT LPTDIVLLLR SSDNSVIRQL VNHPLTKTGN LPHSKTKNVI NYQMRTSEKL
     INLAKGDTGE ATRHARETTN MKTQTVASYF RYSLMDLLSK MVVGQPHFVR CIKPNSERQA
     RKYDKEKVLL QLRYTGILET ARIRRLGFSH RILFANFIKR YYLLCYKSSE EPRMSPDTCA
     TILEKAGLDN WALGKTKVFL KYYHVEQLNL MRKEAIDKLI LIQACVRAFL CSRRYQKIQE
     KRKESAIIIQ SAARGHLVRK QRKEIVDMKN TAVTTIQTSD QEFDYKKNFE NTRESFVKKQ
     AENAISANER FISAPNNKGS VSVVKTSTFK PEEETTNAVE SNNRVYQTPK KMNNVYEEEV
     KQEFYLVGPE VSPKQKSVKD LEENSNLRKV EKEEAMIQSY YQRYTEERNC EESKAAYLER
     KAISERPSYP VPWLAENETS FKKTLEPTLS QRSIYQNANS MEKEKKTSVV TQRAPICSQE
     EGRGRLRHET VKERQVEPVT QAQEEEDKAA VFIQSKYRGY KRRQQLRKDK MSSFKHQRIV
     TTPTEVARNT HNLYSYPTKH EEINNIKKKD NKDSKATSER EACGLAIFSK QISKLSEEYF
     ILQKKLNEMI LSQQLKSLYL GVSHHKPINR RVSSQQCLSG VCKGEEPKIL RPPRRPRKPK
     TLNNPEDSTY YYLLHKSIQE EKRRPRKDSQ GKLLDLEDFY YKEFLPSRSG PKEHSPSLRE
     RRPQQELQNQ CIKANERCWA AESPEKEEER EPAANPYDFR RLLRKTSQRR RLVQQS
//
